实施科学以实现心脏衰竭治疗的公平:美国心脏协会的科学声明
Circulation
|April 3, 2024
概括
对心力衰竭 (HF) 实施指导治疗改善了结果,但差异仍然存在,特别是在女性和少数群体中. 需要更多的研究来确保获得有效的HF治疗.
科学领域:
- 实施科学
- 心血管医学
- 医疗公平
背景情况:
- 根据指导方针进行的医疗和非药物治疗显著改善了心力衰竭患者的生活质量和存活率.
- 尽管有证据表明,符合条件的患者,特别是女性和少数族裔群体, 常常接受这些基于证据的治疗.
- 实施科学提供框架来弥合证据和实践之间的差距,旨在改善健康结果.
研究的目的:
- 提供心力衰竭 (HF) 的实施试验概述.
- 评估HF实施研究中概念框架和健康公平原则的使用情况.
- 为推进医疗保健公平提供务实指导.
主要方法:
- 对心力衰竭现有实施试验的审查.
- 评估研究是否包含理论框架和健康公平方面的考虑.
- 分析用于促进指导方针导向治疗的策略.
主要成果:
- 行为推动,多学科护理和数字健康策略有效地增加了HF的治疗吸收率,但往往缺乏具体的公平目标.
- 很少有HF研究通过参与利益相关者,确定障碍/促进者,制定基于理论的战略或评估以公平为重点的实施措施来全面解决公平问题.
- 现有的HF股权研究表明使用教育策略进行组织变革和公平照顾的可行性,目前正在进行实用试验,探索HF股权.
结论:
- 需要更多专门设计的心力衰竭实践试验,以促进公平的指导治疗.
- 目前在HF的实施策略虽然有效,但需要改进以明确纳入并实现健康公平目标.
- 进一步的研究和实用性试验对于解决差异和确保所有HF患者获得最佳,公平的护理至关重要.
更多相关视频
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
767
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578